Detalhe da pesquisa
1.
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer.
N Engl J Med
; 378(13): 1177-1188, 2018 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29590544
2.
Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 study.
Lancet Oncol
; 20(8): 1070-1082, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31262657
3.
A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance).
Oncologist
; 24(5): 589-e160, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30679315
4.
Development and validation of a model to predict outcomes of colon cancer surveillance.
Cancer Causes Control
; 30(7): 767-778, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31129907
5.
A nomogram for predicting survival and retroperitoneal lymph node dissection treatment in patients with resected testicular germ cell tumors.
J Surg Oncol
; 120(3): 508-517, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31140623
6.
North Central Cancer Treatment Group N0543 (Alliance): A phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinoma.
Cancer
; 123(18): 3494-3501, 2017 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28493308
7.
Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database.
Lancet Oncol
; 17(12): 1709-1719, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27743922
8.
Oral cancer chemotherapy adherence and adherence assessment tools: a report from North Central Cancer Group Trial N0747 and a systematic review of the literature.
J Cancer Educ
; 28(4): 770-6, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23872949
9.
Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials.
J Clin Oncol
; 41(4): 803-815, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36306483
10.
Conversion of non-inferiority margin from hazard ratio to restricted mean survival time difference using data from multiple historical trials.
Stat Methods Med Res
; 31(10): 1819-1844, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35642291
11.
Randomized Phase II Trial of Polyphenon E versus Placebo in Patients at High Risk of Recurrent Colonic Neoplasia.
Cancer Prev Res (Phila)
; 14(5): 573-580, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33648940
12.
Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer.
J Clin Oncol
; 39(6): 631-641, 2021 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33439695
13.
14.
Efficacy of Difluoromethylornithine and Aspirin for Treatment of Adenomas and Aberrant Crypt Foci in Patients with Prior Advanced Colorectal Neoplasms.
Cancer Prev Res (Phila)
; 12(11): 821-830, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31484660
15.
Role of Deficient DNA Mismatch Repair Status in Patients With Stage III Colon Cancer Treated With FOLFOX Adjuvant Chemotherapy: A Pooled Analysis From 2 Randomized Clinical Trials.
JAMA Oncol
; 4(3): 379-383, 2018 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28983557
16.
Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048.
J Clin Oncol
; : JCO2018788620, 2018 Sep 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30204536
17.
Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project.
J Natl Cancer Inst
; 110(6): 638-648, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29267900
18.
Reply to A. Smith et al.
J Clin Oncol
; 40(16): 1844-1846, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35316071
19.
Association of DNA Mismatch Repair and Mutations in BRAF and KRAS With Survival After Recurrence in Stage III Colon Cancers : A Secondary Analysis of 2 Randomized Clinical Trials.
JAMA Oncol
; 3(4): 472-480, 2017 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28006055
20.
Clinical Utility of Metrics Based on Tumor Measurements in Phase II Trials to Predict Overall Survival Outcomes in Phase III Trials by Using Resampling Methods.
J Clin Oncol
; 33(34): 4048-57, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26503199